| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | DC-HIL-expressing myelomonocytic cells are critical promoters of melanoma growth. | J Invest Dermatol | 2014 | 0.81 |
| 2 | DC-HIL+ CD14+ HLA-DR no/low cells are a potential blood marker and therapeutic target for melanoma. | J Invest Dermatol | 2014 | 0.76 |